Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

FDA approves Farxiga for HF patients with reduced ejection fraction

The FDA has approved a new treatment option, Farxiga oral tablets, for adult heart failure patients with reduced ejection fraction.

Thumbnail

What new research tells us about key blood pressure medications and COVID-19

Antihypertensive medications don’t increase a person’s risk of testing positive for COVID-19, according to new research published in the New England Journal of Medicine.

Thumbnail

Costly COVID: AHA braces hospitals, health systems to lose $51B per month

U.S. hospitals and health systems will collectively have lost $202.6 billion to COVID-19’s fiscal jolt by the end of June, the American Hospital Association is projecting.

Thumbnail

COVID-19 puts 1,400 out of work at Michigan Medicine

Michigan Medicine is furloughing or laying off around 1,400 fulltime employees and instituting a hiring freeze that will leave 300 current job openings unfilled. 

Thumbnail

Hospital converts main entrance into COVID x-ray room

Possibly setting a precedent that could be followed in many U.S. hospitals, a medical center in Reading, Pennsylvania, has set up a curbside radiography service specifically for COVID-positive and -suspected patients.

Thumbnail

South Dakota, Hawaii bookend states with fewest, most COVID constraints

Compared with the Aloha State, the Mount Rushmore State is a practical free-for-all during the COVID-19 crisis.

Thumbnail

Almost 80% of US nurses worry about infecting loved ones with COVID-19

A national sampling of more than 15,000 nurses is collectively reporting “infecting family and friends” as the profession’s single most pressing concern during the COVID-19 crisis.

Thumbnail

A potential risk: New studies highlight the connection between treating COVID-19 with hydroxychloroquine and QTc prolongation

Treating COVID-19 patients with hydroxychloroquine, alone or in combination with azithromycin, is associated with an increased risk of QTc prolongation, according to two new studies published in JAMA Cardiology.